A recent study found that DHRS3 was hypermethylated and downregulated in GC patients and reduced expression of DHRS3 is implicated in gastric carcinogenesis, which suggested DHRS3 could be a tumor suppressor [39]. The gene discussed is DHRS3; the disease is neoplasm.